Neuromuscular diseases.
Kelly
John J
JJ
Department of Neurology, The George Washington University Medical Center, Washington, DC, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D018288:Carcinoma, Small Cell / Q000150:complications / Q000276:immunology; D004195:Disease Models, Animal; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000276:immunology; D008175:Lung Neoplasms / Q000150:complications / Q000276:immunology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D018992:Myelin-Associated Glycoprotein / Q000276:immunology; D009468:Neuromuscular Diseases / Q000235:genetics / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D011115:Polyneuropathies / Q000276:immunology / Q000517:prevention & control; D051381:Rats; D000069283:Rituximab; D013482:Superoxide Dismutase / Q000235:genetics*; D000072105:Superoxide Dismutase-1
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D018992:Myelin-Associated Glycoprotein; C000606290:SOD1 protein, human; D000069283:Rituximab; C000606292:Sod1 protein, rat; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1; D009173:Mycophenolic Acid